Analyst Ratings for Melinta Therapeutics Inc. (MLNT)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.8 / 10
Percentile Rank: 36%
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2019 | H.C. Wainwright | Ed Arce | Downgrade | Neutral (Buy) |
N/A (N/A) |
2.85 (0.50) |
-82.46% | Details |
| 6/20/2019 | WBB Securities | N/A | Downgrade | Hold (Speculative Buy) |
N/A (N/A) |
6.41 (0.50) |
-92.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
